The study, performed at (UCLA's) Clark Urology Center, was funded by the Stewart and Lynda Resnick Trust. The Resnicks own POM Wonderful, which provided the juice from the Wonderful variety of pomegranate for the study.The sample size was shamefully small (50 patients), only related to slowing PSA "doubling time" (not actual tumor burden), and the mechanism for this action completely unknown. UCLA "researchers" that permit such conjecture to be promulgated as a press release before more answers exist should be ashamed.
-Wes
1 comment:
And I suppose your prostate's smaller, too, huh?
Post a Comment